Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7302)
All Articles published online
|
Dec 6, 2012 (publication date) through Jan 20, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Nephrology
ISSN
2220-6124
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Florentin M, Elisaf MS. Proton pump inhibitor-induced hypomagnesemia: A new challenge. World J Nephrol 2012; 1(6): 151-154 [PMID: 24175253 DOI: 10.5527/wjn.v1.i6.151] |
|---|---|
| URL: | https://www.wjgnet.com/2220-6124/full/v1/i6/151.htm |
| Number | Citing Articles |
| 1 |
Zuber Khan, Sidharth Mehan, Mohd. Anas Saifi, Ghanshyam Das Gupta, Acharan S. Narula, Reni Kalfin. Proton Pump Inhibitors and Cognitive Health: Review on Unraveling the
Dementia Connection and Co-morbid Risks. Current Alzheimer Research 2023; 20(11): 739 doi: 10.2174/0115672050289946240223050737
|
| 2 |
Sung-Woo Kang, Min Ho An, Seojung Ha, Min-Gyu Kim, Tae Jun Park, Han Ki Kim, Kisung Sheen, Rae Woong Park, Soon Sang Park. Association between gastroesophageal reflux disease and tinnitus in a nationwide population-based cohort study. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-81658-7
|
| 3 |
Lisanne M. M. Gommers, Thomas H. A. Ederveen, Jenny Wijst, Caro Overmars-Bos, Guus A. M. Kortman, Jos Boekhorst, René J. M. Bindels, Jeroen H. F. Baaij, Joost G. J. Hoenderop. Low gut microbiota diversity and dietary magnesium intake are associated with the development of PPI‐induced hypomagnesemia. The FASEB Journal 2019; 33(10): 11235 doi: 10.1096/fj.201900839R
|
| 4 |
Kailin Jiang, Xiaotao Jiang, Yi Wen, Liu Liao, Feng‐bin Liu. Relationship between long‐term use of proton pump inhibitors and risk of gastric cancer: A systematic analysis. Journal of Gastroenterology and Hepatology 2019; 34(11): 1898 doi: 10.1111/jgh.14759
|
| 5 |
Charlie T Seto, Patricio Jeraldo, Robert Orenstein, Nicholas Chia, John K DiBaise. Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility. Microbiome 2014; 2(1) doi: 10.1186/2049-2618-2-42
|
| 6 |
Natasha Daga, Flavian Joseph. Republished: Denosumab-induced severe hypocalcaemia in a patient with vitamin D deficiency. Drug and Therapeutics Bulletin 2021; 59(9): 139 doi: 10.1136/dtb.2021.234508rep
|
| 7 |
Uwe Gröber. Magnesium and Drugs. International Journal of Molecular Sciences 2019; 20(9): 2094 doi: 10.3390/ijms20092094
|
| 8 |
Antonio Ponzetto, Natale Figura. Serum magnesium and the prevalence of peripheral artery disease. Atherosclerosis 2020; 292: 230 doi: 10.1016/j.atherosclerosis.2019.10.020
|
| 9 |
Caitlin Burrell, Li Luo, Marieke Kester Jones, Andrea Lee, Elizabeth Freeman, Copper Aitken-Palmer. HEMATOLOGY AND SERUM BIOCHEMISTRY VALUES OF THE RED PANDA SUBSPECIES (AILURUS FULGENS STYANI). Journal of Zoo and Wildlife Medicine 2018; 49(2): 384 doi: 10.1638/2017-0104.1
|
| 10 |
Ala I. Sharara, Jean M. Chalhoub, Nijmeh Hammoud, Ali H. Harb, Fayez S. Sarkis, Ghassan Hamadeh. Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort. Clinical Gastroenterology and Hepatology 2016; 14(2): 317 doi: 10.1016/j.cgh.2015.10.012
|
| 11 |
Amit Kumar Dutta, Abhinav Jain, Vaneet Jearth, Ramit Mahajan, Manas Kumar Panigrahi, Vishal Sharma, Mahesh Kumar Goenka, Rakesh Kochhar, Govind Makharia, Duvvur Nageshwar Reddy, Richard Kirubakaran, Vineet Ahuja, Neha Berry, Naresh Bhat, Usha Dutta, Uday Chand Ghoshal, Ajay Jain, Umesh Jalihal, V. Jayanthi, Ajay Kumar, Sandeep Nijhawan, Ujjal Poddar, G. N. Ramesh, Shivram P Singh, Showkat Zargar, Shobna Bhatia. Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship. Indian Journal of Gastroenterology 2023; 42(5): 601 doi: 10.1007/s12664-023-01428-7
|
| 12 |
Donald F. Kirby, Soumya Chatterjee. Evaluation and management of gastrointestinal manifestations in scleroderma. Current Opinion in Rheumatology 2014; 26(6): 621 doi: 10.1097/BOR.0000000000000117
|
| 13 |
Sofía Linares Amorós, Ramón Guirao Martínez, Andrea Bernabé Casanova, Sahelys Gómez Hernández. Hipomagnesemia grave secundaria a inhibidores de la bomba de protones, dos casos clínicos. Revista del Laboratorio Clínico 2017; 10(4): 217 doi: 10.1016/j.labcli.2017.07.003
|
| 14 |
Victoria Bîrluţiu, Codruța Mihaela Luca, Rareș-Mircea Bîrluțiu. Streptococcus agalactiae meningoencephalitis associated with gastroesophageal reflux disease and chronic proton pump inhibitors use, in a 9 month-old infant: a case report. BMC Pediatrics 2018; 18(1) doi: 10.1186/s12887-018-0995-0
|
| 15 |
Lisanne M. M. Gommers, Joost G. J. Hoenderop, Jeroen H. F. de Baaij. Mechanisms of proton pump inhibitor‐induced hypomagnesemia. Acta Physiologica 2022; 235(4) doi: 10.1111/apha.13846
|
| 16 |
Isabella D Cooper, Catherine A P Crofts, James J DiNicolantonio, Aseem Malhotra, Bradley Elliott, Yvoni Kyriakidou, Kenneth H Brookler. Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19: rationale for clinical management. Open Heart 2020; 7(2): e001356 doi: 10.1136/openhrt-2020-001356
|
| 17 |
Natasha Daga, Flavian Joseph. Denosumab-induced severe hypocalcaemia in a patient with vitamin D deficiency. BMJ Case Reports 2020; 13(8): e234508 doi: 10.1136/bcr-2020-234508
|
| 18 |
Lidia Romero Calvo, Maria J Garcia-Blanco, Francisco Valenzuela, Javier Álvarez Granda. Osmotic Demyelination Syndrome in a Normonatremic Patient Under Treatment With Proton Pump Inhibitors. Cureus 2023; doi: 10.7759/cureus.44472
|
| 19 |
Robert E. Carroll, Enrico Benedetti, Joseph P. Schowalter, Alan L. Buchman. Management and Complications of Short Bowel Syndrome: an Updated Review. Current Gastroenterology Reports 2016; 18(7) doi: 10.1007/s11894-016-0511-3
|
| 20 |
Mee Onn Chai, Adrian Coleman. Hypomagnesaemia secondary to omeprazole in stage 5 CKD. Journal of Kidney Care 2016; 1(3): 144 doi: 10.12968/jokc.2016.1.3.144
|
| 21 |
Leandro F. Pippa, Valvanera Vozmediano, Lieke Mitrov‐Winkelmolen, Daan Touw, Amira Soliman, Rodrigo Cristofoletti, Wilson Salgado Junior, Natalia Valadares de Moraes. Impact of obesity and roux‐en‐Y gastric bypass on the pharmacokinetics of (R)‐ and (S)‐omeprazole and intragastric pH. CPT: Pharmacometrics & Systems Pharmacology 2024; 13(9): 1528 doi: 10.1002/psp4.13189
|
| 22 |
Mark W. Hess, Jeroen H. F. de Baaij, Lisanne M. M. Gommers, Joost G. J. Hoenderop, René J. M. Bindels, Hauke Smidt. Dietary Inulin Fibers Prevent Proton-Pump Inhibitor (PPI)-Induced Hypocalcemia in Mice. PLOS ONE 2015; 10(9): e0138881 doi: 10.1371/journal.pone.0138881
|
| 23 |
Rachael Flood, John Stack, Geraldine McCarthy. An Update on the Diagnosis and Management of Calcium Crystal Disease. Current Rheumatology Reports 2023; 25(8): 145 doi: 10.1007/s11926-023-01106-9
|
| 24 |
Florence van Hunsel, Laura Peters, Helga Gardarsdottir, Agnes Kant. Assessing the Impact on Health of Pharmacovigilance Activities: Example of Four Safety Signals. Drug Safety 2021; 44(5): 589 doi: 10.1007/s40264-021-01047-1
|
| 25 |
Kristen P Hamilton, Rena Zelig, Anna R Parker, Amina Haggag. Insulin Resistance and Serum Magnesium Concentrations among Women with Polycystic Ovary Syndrome. Current Developments in Nutrition 2019; 3(11): nzz108 doi: 10.1093/cdn/nzz108
|
| 26 |
Singh Saraj Kumar, Goel Khushbu, Mukherji Joy Dev. Hypomagnesaemia induced recurrent cerebellar ataxia: an interesting case with successful management. Cerebellum & Ataxias 2020; 7(1) doi: 10.1186/s40673-019-0110-9
|
| 27 |
James Wei Tatt Toh, Evonne Ong, Robert Wilson. Hypomagnesaemia associated with long-term use of proton pump inhibitors. Gastroenterology Report 2015; 3(3): 243 doi: 10.1093/gastro/gou054
|
| 28 |
Krasimir Kostov. Effects of Magnesium Deficiency on Mechanisms of Insulin Resistance in Type 2 Diabetes: Focusing on the Processes of Insulin Secretion and Signaling. International Journal of Molecular Sciences 2019; 20(6): 1351 doi: 10.3390/ijms20061351
|
| 29 |
Eric Lespessailles, Hechmi Toumi. Proton Pump Inhibitors and Bone Health: An Update Narrative Review. International Journal of Molecular Sciences 2022; 23(18): 10733 doi: 10.3390/ijms231810733
|
| 30 |
Amandeep Singh, Gail A. Cresci, Donald F. Kirby. Proton Pump Inhibitors: Risks and Rewards and Emerging Consequences to the Gut Microbiome. Nutrition in Clinical Practice 2018; 33(5): 614 doi: 10.1002/ncp.10181
|
| 31 |
Arun Koyyada. Long-term use of proton pump inhibitors as a risk factor for various adverse manifestations. Therapies 2021; 76(1): 13 doi: 10.1016/j.therap.2020.06.019
|
| 32 |
Kuen Shan Jih, Ming Fu Wang, Ying Ju Chen. COPD Patients with Acute Exacerbation Who Developed Refeeding Syndrome during Hospitalization Had Poor Outcome: A Retrospective Cohort Study. International Journal of Gerontology 2018; 12(1): 62 doi: 10.1016/j.ijge.2017.03.004
|
| 33 |
Deekshitha Alla, Dhruv Jayeshkumar Shah, Muneesh Seepana, Rishabh Baskara Salian, Sai Santhosha Mrudula Alla, Midhun Krishna Mohanan, Mert Sabıroğlu, Mohan Sai Sunith Vegesna, Aradhya Singh, Srajan Gupta, Shushrutha Shivalingappa Rekha. Safety of Proton Pump Inhibitors in Pediatric Population: A Systematic Review. Global Pediatric Health 2024; 11 doi: 10.1177/2333794X241248967
|
| 34 |
Christopher M. Stark, Cade M. Nylund, Gregory H. Gorman, Brent L. Lechner. Primary renal magnesium wasting: an unusual clinical picture of exercise-induced symptoms. Physiological Reports 2016; 4(8): e12773 doi: 10.14814/phy2.12773
|
| 35 |
Mohamed Saad, Hassan Mitwally. Lansoprazole-Induced Thrombocytopenia in a Critically Ill Patient: A Case Report. Journal of Pharmacy Practice 2020; 33(5): 700 doi: 10.1177/0897190019838681
|
| 36 |
George Liamis, Ewout J. Hoorn, Matilda Florentin, Haralampos Milionis. An overview of diagnosis and management of drug‐induced hypomagnesemia. Pharmacology Research & Perspectives 2021; 9(4) doi: 10.1002/prp2.829
|
| 37 |
Edoardo Savarino, Elisa Marabotto, Patrizia Zentilin, Manuele Furnari, Giorgia Bodini, Gaia Pellegatta, Greta Lorenzon, Marco Della Coletta, Matteo Ghisa, Claudia Coppo, Carla Marinelli, Vincenzo Savarino. A safety review of proton pump inhibitors to treat acid-related digestive diseases. Expert Opinion on Drug Safety 2018; 17(8): 785 doi: 10.1080/14740338.2018.1497155
|
| 38 |
Kaile Chen, Farhad Abtahi, Hong Xu, Carlos Fernandez-Llatas, Juan-Jesus Carrero, Fernando Seoane. The Assessment of the Association of Proton Pump Inhibitor Usage with Chronic Kidney Disease Progression through a Process Mining Approach. Biomedicines 2024; 12(6): 1362 doi: 10.3390/biomedicines12061362
|
| 39 |
Uwe Gröber, Joachim Schmidt, Klaus Kisters. Important drug-micronutrient interactions: A selection for clinical practice. Critical Reviews in Food Science and Nutrition 2020; 60(2): 257 doi: 10.1080/10408398.2018.1522613
|
| 40 |
Stephanie Urwin, Jamie Willows, John A. Sayer. The challenges of diagnosis and management of Gitelman syndrome. Clinical Endocrinology 2020; 92(1): 3 doi: 10.1111/cen.14104
|